ArticleScientific reports2025
Evaluating the impact of radiotherapy on nitrosative stress and thiol/disulfide dynamics in patients with lung cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to prospectively examine the systemic effects of curative radiotherapy on dynamic thiol/disulfide homeostasis and nitrosative stress markers in patients diagnosed with lung cancer. Forty-one patients diagnosed with lung cancer and 41 healthy controls were enrolled in the study. Serum nitric oxide, 3-nitrotyrosine, total thiol, native thiol, and disulfide levels were measured from blood specimens taken from patients before radiotherapy and 24 h after radiotherapy. Nitric oxide levels were analyzed by chemiluminescence technique, 3-nitrotyrosine levels by ELISA, and thiol/disulfide homeostasis parameters by spectrophotometric methods. Serum nitric oxide (NO) and 3-nitrotyrosine levels of patients were significantly elevated in both pre-radiotherapy and post-radiotherapy periods compared to the healthy control group (p < 0.001). NO levels tended to increase after RT, but this difference did not reach statistical significance. Total thiol and native thiol levels in the pre-radiotherapy and post-radiotherapy periods were decreased when compared to the controls (p < 0.001). Post-radiotherapy disulfide levels were markedly higher than the pre-radiotherapy (p < 0.05) and the controls (p < 0.05). Similarly, while disulfide/total thiol and disulfide/native thiol ratios were increased in the post-radiotherapy period, a marked decline was observed in the native thiol/total thiol ratio in the post-radiotherapy period (p < 0.05). Since chemotherapy is also known to affect redox homeostasis, the combined treatment (chemoradiotherapy) is likely responsible for the observed biochemical changes seen in our study. Our suggest that radiotherapy further exacerbates the already imbalanced redox homeostasis in lung cancer patients by enhancing NO production and promoting thiol oxidation. Concurrent chemoradiotherapy appears to exacerbate the imbalance in redox homeostasis in lung cancer patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.